We are live on ! Find out more
ACLX

Arcellx

Delisted

ACLX was delisted on the 27th of April, 2026.

197 hedge funds and large institutions have $4.04B invested in Arcellx in 2025 Q1 according to their latest regulatory filings, with 24 funds opening new positions, 74 increasing their positions, 69 reducing their positions, and 38 closing their positions.

New
Increased
Maintained
Reduced
Closed

165% more call options, than puts

Call options by funds: $51.8M | Put options by funds: $19.6M

17% more funds holding in top 10

Funds holding in top 10: 1214 (+2)

2.67% more ownership

Funds ownership: 109.42%112.09% (+2.7%)

7% more repeat investments, than reductions

Existing positions increased: 74 | Existing positions reduced: 69

7% less funds holding

Funds holding: 211197 (-14)

11% less capital invested

Capital invested by funds: $4.54B → $4.04B (-$495M)

37% less first-time investments, than exits

New positions opened: 24 | Existing positions closed: 38

Holders
197
Holders Change
-14
Holders Change %
-6.64%
% of All Funds
2.64%
Holding in Top 10
14
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+16.67%
% of All Funds
0.19%
New
24
Increased
74
Reduced
69
Closed
38
Calls
$51.8M
Puts
$19.6M
Net Calls
+$32.2M
Net Calls Change
+$29.7M
Name Holding Trade Value Shares
Change
Change in
Stake
GS
1
Gilead Sciences
California
$441M
Fidelity Investments
2
Fidelity Investments
Massachusetts
$414M -$112M -1,652,954 -21%
PBA
3
Paradigm Biocapital Advisors
New York
$295M +$8.16M +120,431 +3%
Vanguard Group
4
Vanguard Group
Pennsylvania
$261M +$44.4M +655,064 +20%
BlackRock
5
BlackRock
New York
$260M +$7.69M +113,548 +3%
NMC
6
NEA Management Company
Maryland
$246M
RCM
7
RA Capital Management
Massachusetts
$199M +$16.9M +249,200 +9%
PA
8
Perceptive Advisors
New York
$192M -$37.4M -552,410 -16%
VPC
9
Vestal Point Capital
New York
$157M +$130M +1,912,720 +403%
SOCM
10
SR One Capital Management
Pennsylvania
$154M
T. Rowe Price Associates
11
T. Rowe Price Associates
Maryland
$121M -$19.1M -281,698 -13%
State Street
12
State Street
Massachusetts
$109M -$7.38M -108,921 -6%
T. Rowe Price Investment Management
13
T. Rowe Price Investment Management
Maryland
$109M +$65M +959,216 +136%
Janus Henderson Group
14
Janus Henderson Group
United Kingdom
$103M -$3.16M -46,598 -3%
CAM
15
Cormorant Asset Management
Massachusetts
$68.9M -$16.9M -250,000 -19%
AIIC
16
AJU IB Investment Company
South Korea
$68.7M
Geode Capital Management
17
Geode Capital Management
Massachusetts
$67M +$2.81M +41,514 +4%
Citadel Advisors
18
Citadel Advisors
Florida
$47.6M +$47.5M +700,901 +2,778%
Capital World Investors
19
Capital World Investors
California
$46.5M +$30.9M +456,496 +181%
JP Morgan Chase
20
JP Morgan Chase
New York
$44.8M +$31.1M +459,125 +205%
Lord, Abbett & Co
21
Lord, Abbett & Co
New Jersey
$43.6M -$21M -310,306 -32%
AAA
22
Affinity Asset Advisors
New York
$34.8M +$7.11M +105,000 +25%
Dimensional Fund Advisors
23
Dimensional Fund Advisors
Texas
$31.9M +$12.3M +181,181 +59%
BAMCO Inc
24
BAMCO Inc
New York
$30.7M +$8.06M +118,928 +34%
Morgan Stanley
25
Morgan Stanley
New York
$30.3M -$10.6M -155,784 -25%

ACLX Hedge Fund Activity: Q1 2025 in Review

197 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in Arcellx (ACLX) for Q1 2025, worth a combined $4.04B — down 11% from $4.54B a quarter earlier.

Sellers outnumbered buyers: 38 funds closed out of ACLX and 24 opened new positions — a net loss of 14 holders — while 69 trimmed existing stakes and 74 added.

The largest buyer was Vestal Point Capital, adding an estimated $130M. The largest seller was Fidelity Investments, cutting an estimated $112M.

  • 197 institutional investors held Arcellx (ACLX) as of Q1 2025, down from 211 in Q4 2024.
  • Funds reported $4.04B of Arcellx stock for Q1 2025, down 11% quarter-over-quarter.
  • 24 funds opened new Arcellx positions in Q1 2025 and 38 closed out, a net change of -14 holders.
  • The largest Arcellx buyer in Q1 2025 was Vestal Point Capital, an estimated $130M added.
  • The largest Arcellx seller in Q1 2025 was Fidelity Investments, an estimated $112M sold.

Based on aggregated 13F filings for Q1 2025.